Use of non-steroid antiinflammatory therapy in COPD patients – Clinical effectiveness and influence on the physical tolerance

L. Iashyna, Y. Feshchenko, T. Pertseva, N. Monogarova, M. Polianska, S. Ishchuk, L. Saveleva (Kiev, Dnepropetrovs'k, Donetsk, Ukraine)

Source: Annual Congress 2010 - COPD: management
Session: COPD: management
Session type: Thematic Poster Session
Number: 4012
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Iashyna, Y. Feshchenko, T. Pertseva, N. Monogarova, M. Polianska, S. Ishchuk, L. Saveleva (Kiev, Dnepropetrovs'k, Donetsk, Ukraine). Use of non-steroid antiinflammatory therapy in COPD patients – Clinical effectiveness and influence on the physical tolerance. Eur Respir J 2010; 36: Suppl. 54, 4012

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The mechanisms of antiinflammatory effect of mucolytic therapy
Source: International Congress 2014 – Predictors
Year: 2014

Oral glucocorticoid treatment of severe asthma – Current practice in the US
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Update on anti-inflammatory therapy in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012


Validation of FEV1 spirometric endpoints as a measure of the anti-inflammatory and bronchodilatory effects of fluticasone/formoterol combination therapy
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013

Effect of low dose theophylline as adjunct in treatment of COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Comparative clinical-functional effectiveness and cardiological safety of short-acting combined broncholytics in 2 months basic therapy in COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 74s
Year: 2007

β2 long-acting and anticholinergic drugs synergistically control TGFβ1-mediated neutrophilic inflammation in COPD: An "in vitro" model
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011


Use of anti-inflammatory therapy for asthma in a tropical setting
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Effectiveness of prolonged cholinolytic in complex basic therapy on the tolerability of physical load in severe bronchial asthma patients
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008

Knemometry assessment of short-term lower leg growth in children with asthma treated with fluticasone propionate/formoterol combination therapy
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


Heliox administration in patients with COPD exacerbation – Technical aspects
Source: Annual Congress 2010 - Mechanical ventilation and weaning
Year: 2010


Next generation of anti-inflammatory therapy for COPD?
Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017
Year: 2017



Comparative assessment of umeclidinium/vilanterol (UMEC/VI) combination therapy among symptomatic COPD patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

The adherence to inhaled drugs in COPD patients: Effect on survival
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015

Study of antioxidant use in patients with asthma exacerbations
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013

Changes in the use of anti-asthmatic medication in an international cohort
Source: Eur Respir J 2005; 26: 1047-1055
Year: 2005



Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Changes in the anti-inflammatory treatment of COPD
Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD
Year: 2012